Public, NASDAQ:VIAP
NASDAQ Capital Market
VIA Pharmaceuticals, Inc. Announces First-In-Human Dosing Of VIA-3196 For Treatment Of Dyslipidemia
Date: Mon, 13 Jun 2011 12:01:00 GMT
Tags:
VIA Pharmaceuticals, Inc. Announces First-In-Human Dosing Of VIA-3196 For Treatment Of Dyslipidemia
Reuters Key Development - Jun 13, 2011
Reuters Key Development - Jun 13, 2011
VIA Pharmaceuticals, Inc. And MHI Announce Publication of VIA-2291 5-Lipoxygenase Inhibitor Clinical Study Data
Date: Thu, 20 May 2010 11:30:00 GMT
Tags:
VIA Pharmaceuticals, Inc. And MHI Announce Publication of VIA-2291 5-Lipoxygenase Inhibitor Clinical Study Data
Reuters Key Development - May 20, 2010
Reuters Key Development - May 20, 2010
VIA Pharmaceuticals, Inc. Announces Strategic Restructuring And Financing
Date: Wed, 31 Mar 2010 20:02:00 GMT
Tags:
VIA Pharmaceuticals, Inc. Announces Strategic Restructuring And Financing
Reuters Key Development - Mar 31, 2010
Reuters Key Development - Mar 31, 2010
Yahoo! Finance: RSS feed not found
Date: Wed, 31 Mar 2010 20:02:00 GMT
Tags:
RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.